100% detection and quantification of SARS-CoV-2 with PBM-HALE, in 1 minute of exhaled breath, requires forced expiration and gives Ct's as low as 25.8. We have updated our preprint with the interim data from our Brazil study 1/n
We had tried to detect COVID-19 in exhaled tidal breath. That's resting breathing to you and me. It didn't work (n=42). We concluded that at least PBM-HALE does what it says on the tin; no environmental contamination, as we sampled in COVID-19 wards with no ventilation. 2/n
However, others were reporting virus in breath samples- most notably @Don_Milton & @drkristenkc - that rose with increasing vocalisation. There is logic to that, as we know this increases aerosol generation. So we went off to Brazil and partnered with Mauro M Texeira at UFMG 3/n
Mauro runs clinical studies in a suburban primary care centre that serves favelas. This is the view from the site where we carried out the study 4/n
This is the actual testing site. Two modified containers, one for participant interviews and recruitment, one for sample collection. Note the natural ventilation (pic 2, taken from door of RHS container) in the room. 5/n
The only one container with air conditioning is the third container (not shown) where pharmaceuticals are kept for various clinical trials. The local power grid cannot take one more A/C unit. I suppose the next level of point of need testing would be in the jungle 6/n.
Like our previous study, we recruited patients positive by lateral flow test (aka rapid antigen test), who were within their first 5 days of symptoms. First they gave a tidal breath 30 min sample. Then they sang "happy birthday" in Portuguese into PBM-HALE for 15 min. 7/n
Unlike @magiorkinis's lab, the Brazilian Dx lab extracted the entire breath sample ~3.6 mL (~120 uL/min), not just 0.2mL or 1mL, to maximise sensitivity, into 30 uL, and loaded 2 uL into the RT-PCR reaction. They also used the US CDC multiplex assay for N1, N2, and RNase P. 8/n
Because there is no RNase P in exhaled tidal breath from the deep lung (there is in saliva), they tested also for 18S rRNA. They used 2 uL of the 30 uL extract, i.e. 6.67% of the sample- or 1 minute's worth of breath sample equivalent. 9/n
As you can see here, there is hardly any virus (none in 3/15 patients) when the patients exhale tidally. Empty data points signify less than 3 of 3 technical replicates being positive for N1 or N2 (i.e. Poisson distribution, non-quantifiable but detectable levels of virus) 10/n
By forced expiration though (i.e. singing) we see Ct's up to 25.8 for SARS-CoV-2, which correlate (p=0.0213) with the 18S values in the sample. In other words, sing into PBM-HALE for 1 min, and we can tell you if you are shedding COVID-19 virus genomes. 11/n
We did not include culture in this study; new samples (n=30) will attempt this, but for some any Ct<32 is considered infectious. Food for thought regarding N95 face masks e.g. @trishgreenhalgh because these are fine aerosols from the deep lung, not just total exhaled breath. 12/n
The clue is in the sampling rate with tidal vs forced expiration. No significant difference in fine aerosol volume captured- because as we've shown PBM-HALE condenses when exhalation has stopped (i.e. during inhalation; eg in pic of 5 sec breath cycle). 13/n
All controls in the Dx lab for extraction, plate positives and negatives, etc. behaved as expected. The beige band Ct 35-40 in the viral load fig is the limit of detection to limit of quantification band for the assay btw. 14/n
In my humble opinion, this is the first direct evidence that fine aerosols from the deep lung, as they exit the mouth, captured without upper airway and large droplet contamination, can contain infectious levels of SARS-CoV-2. I say this cautiously because: 15/n
many other studies that @jljcolorado@linseymarr@kprather88@CathNoakes are familiar with have shown airborne virus, but most, if not every single one, involve pumps, droplet size evolution conditions, etc. Ours explicitly does not allow this to happen. 16/n
And before you mention 0.2 um filters- when wetted, molecules (such as genomes) will go through these filters and nebulise on the other side to contaminate the filtrate. They stop microorganisms, but not their components. 17/n
Happy to be corrected in public if wrong btw- as I've publicly done so for not checking the (faulty) temperature probe measuring -100oC for dry ice in our studies. We've also updated the pre-print for better legibility in places 18/n medrxiv.org/content/10.110…
If you spot any other errors, or have any other methodological or otherwise criticisms to offer, constructively, we welcome them. For me, open science pivots on full pre-print based data sharing and open discussion of what has been done right and what has been done wrong. 19/n
One criticism we received on submission of the previous version of the MS to a top 3 clinical respiratory journal was "the study was not registered". Since this is not an interventional study, our understanding is that no registration is required- we've asked the registers. 20/n
We have presented these data at the @EuroRespSoc#ERS2022 poster #4515 - though the Brazil results have not made the abstract. A copy of the poster will be placed online at @PulmoBioMed's website after the conference. The company will be announcing more important news soon. 21/n
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Our Pre-print on exhaled breath detection of COVID-19 and bacteria from your lung. TL;DR summary: you do not emit any virus if you are infected, have symptoms, and are breathing in a relaxed fashion.
People emit a lot more aeorosols in different ways when they talk, shout, sing, etc. Please wear a mask because we have 3 new variants with more disease burden poised to make our collective summers a mess.
We are working to find out how much virus you emit otherwise 2/n
This starts with a student wanting to test living under bridges with tuberculosis. At the time (2012) pretty much every breath collector out there was considered contaminated, so we set out to solve contamination, sample loss, reproducibility erj.ersjournals.com/content/26/3/5… 3/n
It looks like people aligned with the party in government are paying attention to the first fluttering canary, but not chirping, in the coal mine: Israel. Reduced 4th dose uptake and letting omicron rip has lead to deaths climbing. This was predictable 1/n telegraph.co.uk/global-health/…
And it will also happen here: it’s started already. Why? Because we are starting to fall off the cliff with boosting, testing, and paying attention to mitigations. So the virus is finding fertile ground. And it was all entirely, totally predictable. Let me explain why. 2/n
20 years ago I was finishing off my PhD in vaccines. What I’d learnt through that journey, techniques aside, is that you cannot second guess a pathogen about its response to your attempt to vaccinate against it. (Here’s some data on testing in the U.K. crashing out) 3/n
So it my turn to get COVID19. 2 kids in my 4yo sons’ class tested +ve 12/12/21 so we LFT’d him. He was +ve but asymptomatic; catarrh, cough, mild fever the next day. I developed symptoms 14/12 w/ weak +ve LFT -ve RT-PCR: deep, rattling chesty cough. 1/n
I get these every year but this was on another level. LFTs serially -ve next few days, no notification sons’ +ve was omicron, so I assume he got delta reinfection 8 months on after his first bout of COVID19 (from nursery). 2/n
On 18/12 and whilst still coughing hideously and persistently, which bouts so hard I felt I had no air left, I got my booster which knocked me out the next day. And I mean I spent the whole day asleep level of knocked out. On 20/12/21 my wife also tested +ve by LFT/PCR. 3/n
20 years ago I was in my second year in my PhD busy testing intranasal vaccines for H. pylori infection (stomach ulcers/cancers). We knew back then that dosing the nose raised antibodies throughout all mucosal surfaces. And yet in the clinic we remain reticent.
The reason is the same why SARS-CoV-2 hits your brain: those smell nerves that the virus hitches a ride in to your brain can also prove a problem when vaccinating via the nose. But the benefits can be huge by putting the like of defence at the point of virus entry: the mucous.
We now have 3 independent data sources confirming 40x reduction in nAb efficacy vs omicron and one showing UK’s vaccination strategy particularly weak in that respect. A thread 1/n
Are we screwed? No. Vaccine efficacy is sustained, but significantly lowered for hospitalisation (based on extrapolations from different vaccines and strains) especially in the U.K. where AZ might prove a handicap. Our likelihood of infection even boosted will be higher.
However, this is NOT entirely March 2020 because of steroids, some antivirals (do they work as well on omicron? 🤷♂️), clinical experience, better preparedness. IF we all do our bit (masks, ventilation, work from home) we stand a chance of abating a lockdown.
Today I was interviewed by @BBCLN who presented me as “a scientist” criticising the government. There are another 1000 signatories in the Lancet letter castigating the government. The piece closes with the excuse of higher autumn risk; unfortunately even this is inadmissible. 1/n
When the government defines the terms of reference for the analyses to exclude what WILL make a difference, you can only expect them to raise their hands up in the air and plea no other options. The people need to know the machinations of the modelling. 2/n
Even the modellers admit their models are too erratic and unreliable. So for the government to pretend no other options is *actually*, once again, sand in our eyes. Here’s the interview - a LOT was edited out, and the defence was not presented to me. bbc.co.uk/iplayer/episod…